Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Support for H.R. 5353 /S. 2579 - Eliminating Opioid Related Infectious Diseases Act of 2018. Support for H.R. 6 Sec. 7141 - Support for Patients and Communities Act. Pharmaceutical policy as it relates to payments under the 340B program. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Funding for HCV and public health activities via appropriations.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS